Amalgamated Bank Reduces Stock Holdings in CME Group Inc. (NASDAQ:CME)

Amalgamated Bank reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 2.9% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 72,716 shares of the financial services provider’s stock after selling 2,140 shares during the quarter. Amalgamated Bank’s holdings in CME Group were worth $14,296,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CME. B. Riley Wealth Advisors Inc. increased its holdings in CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC grew its position in shares of CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after acquiring an additional 48 shares during the period. Lantz Financial LLC increased its stake in shares of CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after purchasing an additional 49 shares in the last quarter. Lester Murray Antman dba SimplyRich raised its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares during the period. Finally, Greystone Financial Group LLC lifted its position in CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after purchasing an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on CME shares. Barclays upped their price target on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Finally, Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $209.73.

CME Group Stock Down 0.9 %

Shares of CME stock opened at $216.30 on Thursday. The stock has a market cap of $77.88 billion, a P/E ratio of 24.61, a PEG ratio of 8.85 and a beta of 0.55. The company’s fifty day simple moving average is $207.08 and its two-hundred day simple moving average is $207.54. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the company earned $2.30 earnings per share. The firm’s revenue was up 12.7% on a year-over-year basis. Analysts predict that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

Insider Activity at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.